Check Out JDD Corner’s Latest Author Spotlight Our latest Author Spotlight shines on Mark G. Lebwohl, MD, co-author of “Resolving Hyperkeratotic Psoriasis: Mechanisms of Action and Additive Effects of Fixed-Combination…
Recent Safety and Efficacy Data for Biologics in Psoriasis Treatment options for plaque psoriasis have proliferated significantly in the past decade, with an influx of biologics. With these seemingly interchangeable options,…
A New Outreach Program Demonstrates How Targeted Education Can Transform Access To Dermatologic Care Since its launch in 2020, DermmunityTM, a community service program run by the USC Department of…
A Concise Look at the IMMPulse Trial Comparing Apremilast And Risankizumab In Moderate Plaque Psoriasis In a compelling video interview for the Journal of Drugs in Dermatology, Dr. Christopher Bunick…
Several media outlets covered an August Journal of Drugs in Dermatology survey on the perceived dermatologic side effects of cancer treatments and how those perceptions could impact a person’s decision…
As the most common inflammatory skin disease, Acne Vulgaris is unavoidable in our line of work. By default, we have to be Princes/Princesses of Pimples, though fortunately we have a…
Oatmeal Uncovered: Your New Ally in Skin Health Discover why colloidal oatmeal has earned its spot in modern dermatology. At the JDD Oats in Skincare Educational Resource Center, we’ve assembled…
Transforming Routine Visits into Early‐Warning Systems for Psoriatic Arthritis What if every psoriasis appointment could double as a stealth screening for psoriatic arthritis? In one of our latest JDD articles titled…
Rethinking Spironolactone Dosing in Female Pattern Hair Loss Could a lower dose of spironolactone offer relief to women struggling with thinning hair? Female pattern hair loss (FPHL) is a multifactorial condition…
Elevate your practice with the very latest clinical insights, case studies, and CME, all in one place. Discover the Acne Resource Center - your new go-to microsite for the very…